Landmark study involving babies in Ireland supports use of Cystic Fibrosis drug in infants from four weeks of age
A Cystic Fibrosis drug targeting the basic defect that causes the condition has been shown to be safe and effective in newborns aged four weeks and above, new research involving RCSI University of Medicine and Health Sciences and Children’s Health Ireland has found. The finding is described as a ‘huge moment’ for Cystic Fibrosis by … Read more
